Genetically Modified Cells TRIZ Cases

A serum-free cell culture medium supplements ornithine and putrescine to enhance protein production in animal cell lines.

Automated isolation of induced pluripotent stem cells uses selective binding to remove viral vector integration, reducing manual sub-cloning time.

Genetically modified stem cells deliver suicide genes and immune checkpoint inhibitors directly to tumor sites.

Mutated CD117 variants preserve normal hematopoiesis while allowing specific elimination of cancer cells expressing wild-type antigens.

Controlled agitation and periodic medium exchange maintain high cell densities while minimizing shear stress damage.

Transposon vectors integrate gene fragments into mammalian cell chromosomes, reducing time to establish productive cell lines.

A method for selecting stable recombinant protein producing cell clones by measuring specific marker gene expression levels using quantitative RT-PCR.

Cre-recombinase mediated cassette exchange accelerates reporter line development while maintaining isogenic background consistency across diverse cell lines.

Transfecting acinar cells with a GnT-V plasmid promotes stemness and enables transdifferentiation into functional insulin-secreting cells.

Polydonor CD4+ T cells expressing IL-10 bypass autologous production delays, enabling scalable therapy for graft-versus-host disease.

Synthetic transcription factors modulate endogenous gene expression to drive nuclear reprogramming.

Optimized suspension culture with GSK3β inhibitors and bFGF maintains neural crest cell multipotency during long-term proliferation.

A permanent human cell line enables high-yield transient protein expression through episomal plasmid replication.

A site-directed integration method generates production-competent cell banks with consistent transcription rates.

Re-cloning monoclonal cell lines with optimized selection agents increases therapeutic protein productivity while maintaining quality attributes.

Placental stem cells suppress tumor growth by 20-95% through direct contact, resolving the lack of prior descriptions for this therapeutic approach.

Simultaneous co-electroporation merges viral vector insertion with electroporation, reducing cell stress and maintaining viability above 50%.

TPM1 inhibitors boost megakaryocyte yields from stem cells, addressing insufficient platelet supply for clinical demand.

Therapeutic proteins in erythroid cells retain elevated concentrations by hindering ubiquitination during maturation, avoiding global cell function disruption.

Donor cells evade immune recognition by modifying MHC I proteins and expressing HLA-E or HLA-G to prevent rejection without systemic immunosuppression.

N-acyl-X-glutamine dipeptides stabilize glutamine delivery during heat sterilization, preventing pyroglutamate formation and maintaining cell productivity.

Inverting adult distal lung organoids exposes apical ACE2 receptors, enabling direct SARS-CoV-2 infection modeling without feeder cells.

Optogenetic tools normalize pathological action potential properties to suppress arrhythmogenicity without irreversible tissue damage.

A pluripotent stem cell induction composition combines miR-290 family microRNAs with specific small-molecule inhibitors to drive cellular reprogramming.

Antibodies bind intracellular survivin epitopes via peptide vaccine intermediaries to overcome targeting limitations.

A stem cell culture medium containing GSK3beta, MEK 1/2, and TGF beta inhibitors maintains pluripotency in bovine cells.

A CHO cell expression system uses DHFR deficiency and prokaryotic markers to produce recombinant proteins in serum-free media.

IL2 muteins activate intermediate affinity receptors to expand central memory lymphocytes, avoiding regulatory T cell dampening of antitumor immunity.

Pulsed electromagnetic signals disrupt cell membranes to improve intracellular delivery and protein expression, overcoming skin barrier resistance.

Carbohydrate phosphonate derivatives inhibit fucosylation enzymes in cell culture media to modulate antibody glycosylation patterns.

Fully human anti-CD38 antibodies eliminate dependency on stroma cells or cytokines to induce apoptosis in diverse CD38-positive cell types.

Stable transposon integration of SV40 T antigen and telomerase genes eliminates retroviral LTR risks while ensuring consistent cell line characteristics.

Reprogramming transcription factors convert non-pluripotent cells directly into cardiomyocytes without pluripotent intermediates.

A method for inducing non-clonal immortalization of human epithelial cells by targeting senescence barriers.

Shifting cell metabolism to consume lactate resolves the contradiction between high productivity and waste accumulation, boosting protein titers.

FAM60A impairment stabilizes recombinant protein expression in eukaryotic cells, reducing productivity losses and shortening clone selection time.

Human iPSC-derived triculture system combines neurons and glial cells to enhance neuronal maturation and activity.

Transient MLLT3 overexpression expands human hematopoietic stem cells, extending maintenance duration and improving transplantation viability.

A bulk culture method expands reprogrammed cells without manual colony isolation.

Combining MyoD1 and L-myc genes bypasses pluripotent stem cell risks to induce efficient human myoblasts.

Anti-TNFR2 antibodies overcome limited targeting reliability by inhibiting TNFR2 signaling to treat cancers and autoimmune diseases.

Reducing BCL2L11 while increasing BATF3 in lymphocytes overcomes exhaustion, sustaining anti-tumor efficacy.

Self-assembled three-dimensional RNA constructs express transcription factors to induce direct reprogramming of somatic cells.

Pre-selects high-capacity iPS cells via TRIM58 and FAM19A5 markers to resolve low differentiation efficiency in hematopoietic production.

A process for expanding autologous T cells using peptide-pulsed dendritic cells and artificial co-stimulatory factors.

Flow electroporation transfects cells with expression constructs, reducing time and resources required to identify high-producing stable cell lines.

Modulating neuregulin-1 and ErbB receptors produces enriched cardiomyocyte populations with defined electrophysiological properties.